Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura

Acta Paediatrica, International Journal of Paediatrics

Volumn 88, Issue 6, 1999, Pages 614-617

  Heegaard, E D ^a   Rosthoj S ^b   Petersen, B L ^a   Nielsen, S ^a   Karup Pedersen, F ^a   Hornsleth, A ^a  

^a Rigshospitalet   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Idiopathic thrombocytopenic purpura; Immunoglobulin; Parvovirus B19; Polymerase chain reaction

Indexed keywords

IMMUNOGLOBULIN; STEROID; VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROID PRECURSOR CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOMODULATION; INFANT; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; VIRUS TYPING;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS; ANTIGENS, VIRAL; BONE MARROW; CHILD; CHRONIC DISEASE; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GLOBINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOHISTOCHEMISTRY; MALE; METHYLPREDNISOLONE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0032969313     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035259950169251     Document Type: Article

References (30)

1. Heegaard ED, Hornsleth A. Parvovirus: the expanding spectrum of disease. Acta Paediatr 1995; 84: 109-17
2. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, et al. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257-64
3. Potter CG, Potter AC, Hatton CSR, Chapel HM, Anderson MJ, Pattison JR, et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest 1987; 79: 1486-92
4. Nagai K, Morohoshi T, Kudoh T, Yoto Y, Suzuki N, Matsunaga Y. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Br J Haematol 1992; 80: 131-2
5. Oeda E, Shinohara K, Inoue H, Nomiyama J. Parvovirus B19 infection causing severe peripheral blood thrombocytopenia and persistent viremia. Am J Hematol 1994; 45: 274-5
6. Inoue S, Kinra NK, Mukkamala SR, Gordon R. Parvovirus B19 infection: aplastic crisis, erythema infectiosum and idiopathic thrombocytopenic purpura. Pediatr Infect Dis J 1991; 10: 251-3
7. Foreman NK, Oakhill A, Caul EO. Parvovirus-associated thrombocytopenic purpura [Letter]. Lancet 1988; 2: 1426-7
8. Blanche P, Wyplosz B, Herry I, Salmon D, Sicard D. Pure red cell aplasia, peripheral thrombocytopenic purpura, and parvovirus B19 infection in a woman seropositive for human immunodeficiency virus. Clin Infect Dis 1994; 19: 215
9. Hanada T, Koike K, Hirano C, Takeya T, Suzuki T, Matsunaga Y, et al. Childhood transient erythroblastopenia complicated by thrombocytopenia and neutropenia. Eur J Haematol 1989; 42: 77-80
10. Dike N, Miyamura T, Obama K, Takahira H, Sato H, Kozuru M. Parvovirus B19-associated haemophagocytosis in Evans syndrome: aplastic crisis accompanied by severe thrombocytopenia. Br J Haematol 1993; 84: 530-2
11. Wright IMR, Williams ML, Cohen BJ. Congenital parvovirus infection. Arch Dis Child 1991; 66: 253-4
12. Murray JC, Morad AB, Pierce MA, Mihm S. Thrombocytopenia accompanying early postnatal infection by human parvovirus B19. Am J Hematol 1995; 49: 360
13. Kaplan C, Morinet F, Cartron J. Virus-induced autoimmune thrombocytopenia and neutropenia. Semin Hematol 1992; 29: 34-44
14. Lefrere JJ, Courouce AM, Kaplan C. Parvovirus and idiopathic thrombocytopenic purpura [Letter]. Lancet 1989; 1: 279
15. Yoto Y, Kudoh T, Suzuki N, Katoh S, Matsunaga Y, Chiba S. Thrombocytopenia induced by human parvovirus B19 infections. Eur J Haematol 1993; 50: 255-7
16. van Elsacker-Niele A-MW, Weiland HT, Kroes ACM, Kappers-Klunne MC. Parvovirus B19 infection and idiopathic thrombocytopenic purpura. Ann Hematol 1996; 72: 141-4
17. Baranski B, Young N. Hematologic consequences of viral infections. Hematol Oncol Clin North Am 1987; 1: 167-83
18. Ozsoylu S, Kanra G, Savas G. Thrombocytopenic purpura related to rubella infection. Pediatrics 1978; 62: 567-9
19. Tamir D, Benderly A, Levy J, Ben-Porath E, Vonsover A. Infectious mononucleosis and Epstein-Barr virus in childhood. Pediatrics 1974; 53: 330-5
20. Wright JF, Blanchette VS, Wang H, Arya N, Petric M, Semple JW, Chia W-K, Freedman J. Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP). Br J Haematol 1996; 95: 145-52
21. Murray JC, Kelley PK, Hogrefe WR, McClain KL. Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection. Am J Pediatr Hematol/Oncol 1994; 16: 314-9
22. Rosthøj S, Nielsen S, Karup Pedersen F, and the Danish I.T.P. Study Group. Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Acta Pødiatr 1996; 85: 910-5
23. Heegaard ED, Hasle H, Clausen N, Hornsleth A, Kerndrup GB. Parvovirus B19 infection and Diamond-Blackfan anaemia. Acta Pædiatr 1996; 85: 299-302
24. Hornsleth A, Carlsen KM, Christensen LS, Gundestrup M, Heegaard ED, Myhre J. Estimation of serum concentration of parvovirus B19 DNA by PCR in patients with chronic anaemia. Res Virol 1994; 145: 379-86
25. Hasle H, Kerndrup G, Jacobsen BB, Heegaard ED, Hornsleth A, Lillevang ST. Chronic parvovirus infection mimicking myelodysplastic syndrome in a child with subclinical immunodeficiency. Am J Pediatr Hematol/Oncol 1994; 16: 329-33
26. Wright C, Hinchliffe SA, Taylor C. Fetal pathology in intrauterine death due to parvovirus B19 infection. Br J Obstet Gynaecol 1996; 103: 133-6
27. Srivastava A, Bruno E, Briddell R, Cooper R, Srivastava C, van Besien K, et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 1990; 76: 1997-2004
28. Ozawa K, Ayub J, Kajigaya S, Shimada T, Young N. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol 1988; 62: 2884-9
29. Sasaki T, Takahashi Y, Yoshinaga K, Sugamura K, Shiraishi H. An association between human parvovirus B-19 infection and autoantibody production. J Rheumatol 1989; 16: 708-9
30. Soloninka CA, Anderson MJ, Laskin CA. Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19. J Rheumatol 1989; 16: 777-81